StonvexLoading…
StonvexStonvexStonvexCore line items from LEN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-02-28 | Annual 2025 2025-11-30 | Q3 2025 2025-08-31 | Q2 2025 2025-05-31 |
|---|---|---|---|---|
Revenue | $6.62B | $34.19B | $24.82B | $16.01B |
Operating Income | $302.45M | $2.81B | $2.13B | $1.34B |
Net Income | $229.38M | $2.08B | $1.59B | $996.98M |
EPS (Diluted) | $0.93 | $7.98 | $6.06 | $3.77 |
Total Assets | $33.21B | $34.43B | $34.88B | $34.37B |
Total Liabilities | $11.18B | $12.29B | $12.13B | $11.64B |
Cash & Equivalents | $2.39B | $3.76B | $1.76B | $1.48B |
Free Cash Flow OCF − CapEx | $-463.49M | $28.18M | $-1.65B | $-1.46B |
Shares Outstanding | 244.44M | 257.75M | 259.54M | 261.51M |